Circio Holding ASA (OSL:CRNA)

Norway flag Norway · Delayed Price · Currency is NOK
1.090
-0.060 (-5.22%)
At close: Oct 23, 2025
-5.22%
Market Cap118.64M
Revenue (ttm)n/a
Net Income (ttm)-6.60M
Shares Out108.84M
EPS (ttm)-0.11
PE Ration/a
Forward PE1.70
Dividendn/a
Ex-Dividend Daten/a
Volume2,981,128
Average Volume7,838,637
Open1.134
Previous Close1.150
Day's Range1.074 - 1.200
52-Week Range0.480 - 3.310
Beta1.61
RSI53.20
Earnings DateNov 6, 2025

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company was formerly known as Targovax ASA and changed its name to Circio Holdi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 10
Stock Exchange Oslo Børs
Ticker Symbol CRNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.